amplification

(redirected from Nucleic Acid Amplification)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms.

amplification

[‚am·plə·fə′kā·shən]
(genetics)
Treatment with an antibiotic or other agent to increase the relative proportion of plasmid to bacterial deoxyribonucleic acid.
Bulk replication of a gene library.
(science and technology)
The production of an output of greater magnitude than the input.
References in periodicals archive ?
While PCR and RT-PCR thus remain the mainstays of molecular diagnostic approaches, approaches such as these which omit nucleic acid amplification strategies offer additional tools in the laboratory toolbox with features and utility ideally suited to some applications.
The scope of the problem is difficult to define because many nucleic acid amplification tests do not include IACs.
Desired Changes to Nucleic Acid Amplification Products
A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labeled probes.
Browse 31 market data Tables and 53 Figures spread through 215 P ages and in-depth TOC on "Isothermal Nucleic Acid Amplification Technology (INAAT)"
The provision relates to a system service to search for constituents viral HCV, HIV / 1, HBV by nucleic acid amplification technique (NAT) on the blood and blood components intended for transfusion for the region of Basilicata.
Today Percepta Associates announces the launch of the 2011 Nucleic Acid Amplification Series 3 Life Science Dashboard[TM] market research report, providing rapid access to actionable key market indicators for the nucleic acid amplification market.
com adds "Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018" report to its research database.
com/research/mr6nm8/global_isothermal) has announced the addition of the "Global Isothermal Nucleic Acid Amplification Technologies Market 2014-2018" report to their offering.
Real-time PCR has become the method of choice for nucleic acid amplification and new aftermarket products and assays are driving demand.
Any available serum and myocardial tissue specimens from patients were tested at the California Department of Health Services Viral and Rickettsial Disease Laboratory by using real-time PCR nucleic acid amplification (Amersham Eclipse, Piscataway, NJ, USA) and immunoglobulin M (IgM) enzyme immunoassay for detecting enterovirus and adenovirus (10,11).